2,3',4',5-テトラクロロビフェニル
(1) (2) (3) (4) (1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (1) (2) (3) (4) S&L (1) (2) (3) S&L (4) (5) (1) (2) (3) (4) (1) (2) 2 New York
64
2) 3) LAN 4) 2 5) 6) 7) K MIC NJR4261JB0916 8) 24.11GHz V 5V 3kHz 4 (1) (8) (1)(5) (2)(3)(4)(6)(7) (1) (2) (3) (4)
8
4) 5) ) ( 1 ) ( 2 ) ( 3 ) ( 4 ) ( 5 ) ( 6 ) )8) ( 1 ) ( 2 ) ( 3 ) ( 200 9) ( 10) 1 2 (
8
1: n n e = φ(n) e 2 [2] 1 [1] 3 [3] 2 [2] 4 [2,2] 2 [2] 5 [5] 4 [2,2] 6 [2,3] 2 [2] 7 [7] 6 [2,3] 8 [2,2,2] 4 [2,2] 9 [3,3] 6 [2,3] 10 [2,5] 4 [2,2] 1
11
edaenumerate (1) (2) (3) (4) (5) (6) (7) (8) (9) 2. 3 edaenumerate edaenumerate 2 <..> \begin{enumerate}<3> (1) (2) (3) (4) (5) (6) (7) (8) (9)
15
3 2 2 (1) (2) (3) (4) 4 4 AdaBoost 2. [11] Onishi&Yoda [8] Iwashita&Stoica [5] 4 [3] 3. 3 (1) (2) (3)
6
2 Eclipse 2.1 Eclipse 1. Eclipse 2. 3 ( 4) E:Yworkspace OK 3 Eclipse 4 3. Eclipse 5 5 Eclipse Eclipse 2. 7 C 2
14
(1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3)
99
I 01NA AB 4,5,,. (),,,. (),,,,.,..,,.,. 1, ( 2, 1-1, ),,,.. 2 (2-5),,, ( ),. 3 (1): (1-2-2, ),., ( ). 4 (2): ( ), (),. 5
158
(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
55
J 1 J 2 J 3 J 1.J 4 J J J 5 J 6 J 1 J 2. J 2 GPIF J 3 4 J 1 J J NISA 3. J 2 REIT 3 J 4 JETF 5 J 1 J 4. J 2 J 3 J 4 J 5 REIT 5. 1
70
Lyra X Y X Y ivis Designer Lyra ivisdesigner Lyra ivisdesigner 2 ( 1 ) ( 2 ) ( 3 ) ( 4 ) ( 5 ) (1) (2) (3) (4) (5) Iv Studio [8] 3 (5) (4) (1) (
8
PR E/A, PVR 1, 2, 2, 3, 3, 3, 3, 4, 5, 2 1, 2, 3, 4, 5,ASE, ,21 54, sniff 5 5,2 ASE,, 21 mm 20 sniff 50 3 mmhg, 21 mm 20 sniff mmhg, 8 m
12
(1) 2 (2) 2 (3) 3 (4) 3 (5) 6 (6) 13 (7) (1) 16 (2) 16 (3) 17 (4) 17 (5) 19 (6) (1) 20 (2) (1) 23 (2) 23 (3) 23 (4
29
CQ antiepileptic drugs AED AED 4 AED 2,3 AED AED 1 AED 4,5 AED 4 10% 2 5% 2 3 AED 2,5,6 AED CQ
11
(1) (2) (3) (4) (5) (6) (7) (8) (9) (1) (2) (3) (4)
27
,2) 3) 2) 4) 2) 5) 5) 6) 6) 1,2) class 19.5 MRI 21x15 calponin p SPA Key words: 1) 2) 3) 4) 5) 6) Masa
5
JIS Web Web JIS JIS 5.1.a 5.1.b 5.2.a 5.2.b 5.2.c 5.2.d 5.2.e 5.2.f 5.2.g 5.3.a 5.3.b 5.3.c 5.3.d 5.3.e 5.3.f 5.3.g 5.3.h 5.3.i 5.4.a 5.4.b 5.4.c 5.4.
56
9 1 (1) (2) (3) (4) (5) (1)-(5) (i) (i + 1) 4 (1) (2) (3) (4) (5) (1)-(2) (1)-(5) (5) 1
17
目 次 1 調査概要 2 (1) 調査目的 3 (2) 調査対象 3 (3) 抽出方法 3 (4) 調査回収 3 (5) 調査期間 3 (6) 調査主体 3 (7) 回収結果 3 (8) 集計における注意点 3 2 回答者の属性 4 (1) 性別 5 (2) 年齢 5 (3) 家族構成 5 (4)
112